ribavirin has been researched along with Carcinoma, Anaplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, CC; Borden, KL; Cocolakis, E; Culjkovic-Kraljacic, B; Dobocan, MC; Flores, LM; Krop, IE; Miller, WH; Pettersson, F; Puckett, R; Retrouvay, H; Retrouvey, H; Rousseau, C; Yau, C | 1 |
| Monden, Y; Prajda, N; Taniki, T; Weber, G | 1 |
| Li, W; Weber, G | 1 |
| Dobrynin, IaV; Lichinitser, MR; Lobova, TG; Nikolaeva, TG; Zharkov, SA | 1 |
4 other study(ies) available for ribavirin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cells, Cultured; Eukaryotic Initiation Factor-4E; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mammary Glands, Human; Organ Specificity; Prognosis; Ribavirin; RNA, Small Interfering; Up-Regulation | 2011 |
Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Adenosquamous; Cell Division; Drug Screening Assays, Antitumor; Drug Synergism; Female; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Rats; Ribavirin; Spindle Apparatus; Tumor Cells, Cultured | 1993 |
Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma; Drug Screening Assays, Antitumor; Drug Synergism; Female; Genistein; Growth Inhibitors; Humans; Ovarian Neoplasms; Ribavirin; Tumor Cells, Cultured | 1998 |
[Ribamidil as a modulator of the toxic effect of 5-fluorouracil].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cells, Cultured; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Ovarian Neoplasms; Ribavirin; Ribonucleosides | 1985 |